ID   TRBC1_HUMAN             Reviewed;         176 AA.
AC   P01850; A0A0J9YYE9; A0A5B8; A6NH51;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   18-JUL-2018, sequence version 4.
DT   28-JAN-2026, entry version 182.
DE   RecName: Full=T cell receptor beta constant 1 {ECO:0000303|Ref.7};
GN   Name=TRBC1 {ECO:0000303|Ref.7};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (IMGT ALLELE TRBC1*01).
RX   PubMed=6336315; DOI=10.1038/308145a0;
RA   Yanagi Y., Yoshikai Y., Leggett K., Clark S.P., Aleksander I., Mak T.W.;
RT   "A human T cell-specific cDNA clone encodes a protein having extensive
RT   homology to immunoglobulin chains.";
RL   Nature 308:145-149(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (IMGT ALLELE TRBC1*01).
RX   PubMed=3860845; DOI=10.1073/pnas.82.15.5068;
RA   Tunnacliffe A., Kefford R., Milstein C., Forster A., Rabbitts T.H.;
RT   "Sequence and evolution of the human T-cell antigen receptor beta-chain
RT   genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:5068-5072(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (IMGT ALLELE TRBC1*01).
RX   PubMed=8650574; DOI=10.1126/science.272.5269.1755;
RA   Rowen L., Koop B.F., Hood L.;
RT   "The complete 685-kilobase DNA sequence of the human beta T cell receptor
RT   locus.";
RL   Science 272:1755-1762(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (IMGT ALLELE TRBC1*01).
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (IMGT ALLELE TRBC1*01).
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION, DOMAIN, AND MUTAGENESIS OF GLN-139.
RX   PubMed=9382891; DOI=10.1084/jem.186.11.1933;
RA   Baeckstroem B.T., Hausmann B.T., Palmer E.;
RT   "Signaling efficiency of the T cell receptor controlled by a single amino
RT   acid in the beta chain constant region.";
RL   J. Exp. Med. 186:1933-1938(1997).
RN   [7]
RP   NOMENCLATURE.
RA   Lefranc M.P., Lefranc G.;
RT   "The T Cell Receptor FactsBook.";
RL   (In) Lefranc M.P., Lefranc G. (eds.);
RL   The T Cell Receptor FactsBook., pp.1-397, Academic Press, London. (2001).
RN   [8]
RP   REVIEW ON T CELL REPERTOIRE DIVERSITY.
RX   PubMed=15040585; DOI=10.1038/nri1292;
RA   Nikolich-Zugich J., Slifka M.K., Messaoudi I.;
RT   "The many important facets of T-cell repertoire diversity.";
RL   Nat. Rev. Immunol. 4:123-132(2004).
RN   [9]
RP   REVIEW ON T CELL RECEPTOR-CD3 COMPLEX ASSEMBLY, AND SUBCELLULAR LOCATION.
RX   PubMed=20452950; DOI=10.1101/cshperspect.a005140;
RA   Wucherpfennig K.W., Gagnon E., Call M.J., Huseby E.S., Call M.E.;
RT   "Structural biology of the T-cell receptor: insights into receptor
RT   assembly, ligand recognition, and initiation of signaling.";
RL   Cold Spring Harb. Perspect. Biol. 2:A005140-A005140(2010).
RN   [10]
RP   REVIEW ON T CELL RECEPTOR SIGNALING.
RX   PubMed=23524462; DOI=10.1038/nri3403;
RA   Brownlie R.J., Zamoyska R.;
RT   "T cell receptor signalling networks: branched, diversified and bounded.";
RL   Nat. Rev. Immunol. 13:257-269(2013).
RN   [11]
RP   NOMENCLATURE.
RX   PubMed=24600447; DOI=10.3389/fimmu.2014.00022;
RA   Lefranc M.P.;
RT   "Immunoglobulin and T Cell Receptor Genes: IMGT((R)) and the Birth and Rise
RT   of Immunoinformatics.";
RL   Front. Immunol. 5:22-22(2014).
RN   [12]
RP   REVIEW ON FUNCTION.
RX   PubMed=25493333; DOI=10.1146/annurev-immunol-032414-112334;
RA   Rossjohn J., Gras S., Miles J.J., Turner S.J., Godfrey D.I., McCluskey J.;
RT   "T cell antigen receptor recognition of antigen-presenting molecules.";
RL   Annu. Rev. Immunol. 33:169-200(2015).
RN   [13]
RP   DISULFIDE BOND, SUBUNIT, MUTAGENESIS OF VAL-162, AND DOMAIN.
RX   PubMed=27791034; DOI=10.1073/pnas.1611445113;
RA   Krshnan L., Park S., Im W., Call M.J., Call M.E.;
RT   "A conserved alphabeta transmembrane interface forms the core of a compact
RT   T-cell receptor-CD3 structure within the membrane.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E6649-E6658(2016).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 1-129 IN COMPLEX WITH HLA-A/B2M
RP   HETERODIMER AND TRAC.
RX   PubMed=12796775; DOI=10.1038/ni942;
RA   Stewart-Jones G.B.E., McMichael A.J., Bell J.I., Stuart D.I., Jones E.Y.;
RT   "A structural basis for immunodominant human T cell receptor recognition.";
RL   Nat. Immunol. 4:657-663(2003).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-129 IN COMPLEX WITH HLA-B/B2M
RP   HETERODIMER AND TRAC, AND DISULFIDE BOND.
RX   PubMed=19167249; DOI=10.1016/j.immuni.2008.11.011;
RA   Gras S., Burrows S.R., Kjer-Nielsen L., Clements C.S., Liu Y.C.,
RA   Sullivan L.C., Bell M.J., Brooks A.G., Purcell A.W., McCluskey J.,
RA   Rossjohn J.;
RT   "The shaping of T cell receptor recognition by self-tolerance.";
RL   Immunity 30:193-203(2009).
CC   -!- FUNCTION: Constant region of T cell receptor (TR) beta chain
CC       (PubMed:24600447). Alpha-beta T cell receptors are antigen specific
CC       receptors which are essential to the immune response and are present on
CC       the cell surface of T lymphocytes. Recognize peptide-major
CC       histocompatibility (MH) (pMH) complexes that are displayed by antigen
CC       presenting cells (APC), a prerequisite for efficient T cell adaptive
CC       immunity against pathogens (PubMed:25493333). Binding of alpha-beta TR
CC       to pMH complex initiates TR-CD3 clustering on the cell surface and
CC       intracellular activation of LCK that phosphorylates the ITAM motifs of
CC       CD3G, CD3D, CD3E and CD247 enabling the recruitment of ZAP70. In turn,
CC       ZAP70 phosphorylates LAT, which recruits numerous signaling molecules
CC       to form the LAT signalosome. The LAT signalosome propagates signal
CC       branching to three major signaling pathways, the calcium, the mitogen-
CC       activated protein kinase (MAPK) kinase and the nuclear factor NF-kappa-
CC       B (NF-kB) pathways, leading to the mobilization of transcription
CC       factors that are critical for gene expression and essential for T cell
CC       growth and differentiation (PubMed:23524462, PubMed:9382891). The T
CC       cell repertoire is generated in the thymus, by V-(D)-J rearrangement.
CC       This repertoire is then shaped by intrathymic selection events to
CC       generate a peripheral T cell pool of self-MH restricted, non-
CC       autoaggressive T cells. Post-thymic interaction of alpha-beta TR with
CC       the pMH complexes shapes TR structural and functional avidity
CC       (PubMed:15040585). {ECO:0000269|PubMed:9382891,
CC       ECO:0000303|PubMed:15040585, ECO:0000303|PubMed:23524462,
CC       ECO:0000303|PubMed:24600447, ECO:0000303|PubMed:25493333}.
CC   -!- SUBUNIT: Alpha-beta TR is a heterodimer composed of an alpha and beta
CC       chain; disulfide-linked. The alpha-beta TR is associated with the
CC       transmembrane signaling CD3 coreceptor proteins to form the TR-CD3 (TcR
CC       or TCR). The assembly of alpha-beta TR heterodimers with CD3 occurs in
CC       the endoplasmic reticulum where a single alpha-beta TR heterodimer
CC       associates with one CD3D-CD3E heterodimer, one CD3G-CD3E heterodimer
CC       and one CD247 homodimer forming a stable octameric structure. CD3D-CD3E
CC       and CD3G-CD3E heterodimers preferentially associate with TR alpha and
CC       TR beta chains, respectively. The association of the CD247 homodimer is
CC       the last step of TcR assembly in the endoplasmic reticulum and is
CC       required for transport to the cell surface.
CC       {ECO:0000269|PubMed:27791034, ECO:0000303|PubMed:20452950}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000303|PubMed:20452950}.
CC   -!- DOMAIN: The connecting peptide (CP) domain is essential for signal
CC       transmission in response to antigenic stimulation, likely downstream
CC       from ZAP70 recruitment. {ECO:0000269|PubMed:9382891}.
CC   -!- DOMAIN: The TM domain mediates the interaction with the CD3 subunits.
CC       {ECO:0000269|PubMed:27791034}.
CC   -!- POLYMORPHISM: There are several alleles. The sequence shown is that of
CC       IMGT allele TRBC1*01. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA25134.1; Type=Miscellaneous discrepancy; Note=Chimeric mRNA corresponding to regions V, J and C of T cell receptor (TR) alpha chain.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X00437; CAA25134.1; ALT_SEQ; mRNA.
DR   EMBL; M12887; AAA60661.1; -; Genomic_DNA.
DR   EMBL; L36092; AAC80213.1; -; Genomic_DNA.
DR   EMBL; AC245427; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471198; EAW51914.1; -; Genomic_DNA.
DR   PIR; B25777; RWHUCY.
DR   PDB; 1AO7; X-ray; 2.60 A; E=1-129.
DR   PDB; 1FYT; X-ray; 2.60 A; E=1-133.
DR   PDB; 1J8H; X-ray; 2.40 A; E=1-133.
DR   PDB; 1KGC; X-ray; 1.50 A; E=1-129.
DR   PDB; 1KTK; X-ray; 3.00 A; E/F=4-129.
DR   PDB; 1MI5; X-ray; 2.50 A; E=1-129.
DR   PDB; 1OGA; X-ray; 1.40 A; E=1-129.
DR   PDB; 1YMM; X-ray; 3.50 A; E=1-130.
DR   PDB; 1ZGL; X-ray; 2.80 A; P/R/T/V=1-130.
DR   PDB; 2AK4; X-ray; 2.50 A; E/J/P/U=1-129.
DR   PDB; 2AXH; X-ray; 2.70 A; A/B=1-129.
DR   PDB; 2BNQ; X-ray; 1.70 A; E=1-129.
DR   PDB; 2BNR; X-ray; 1.90 A; E=1-129.
DR   PDB; 2BNU; X-ray; 1.40 A; B=1-129.
DR   PDB; 2CDE; X-ray; 3.50 A; B/D/F=1-129.
DR   PDB; 2CDF; X-ray; 2.25 A; B=1-129.
DR   PDB; 2CDG; X-ray; 2.60 A; B=1-129.
DR   PDB; 2ESV; X-ray; 2.60 A; E=1-129.
DR   PDB; 2F53; X-ray; 2.10 A; E=1-129.
DR   PDB; 2F54; X-ray; 2.70 A; E/L=5-129.
DR   PDB; 2GJ6; X-ray; 2.56 A; E=1-129.
DR   PDB; 2IAL; X-ray; 1.92 A; B/D=1-129.
DR   PDB; 2IAM; X-ray; 2.80 A; D=1-129.
DR   PDB; 2IAN; X-ray; 2.80 A; E/J/O/T=1-129.
DR   PDB; 2NTS; X-ray; 2.40 A; P=5-127.
DR   PDB; 2NW2; X-ray; 1.40 A; B=1-129.
DR   PDB; 2NX5; X-ray; 2.70 A; E/J/P/U=1-129.
DR   PDB; 2P5E; X-ray; 1.89 A; E=1-129.
DR   PDB; 2P5W; X-ray; 2.20 A; E=1-129.
DR   PDB; 2PO6; X-ray; 3.20 A; D/H=1-129.
DR   PDB; 2PYE; X-ray; 2.30 A; E=1-129.
DR   PDB; 2PYF; X-ray; 2.20 A; B=1-129.
DR   PDB; 2VLJ; X-ray; 2.40 A; E=1-129.
DR   PDB; 2VLK; X-ray; 2.50 A; E=1-129.
DR   PDB; 2VLM; X-ray; 1.98 A; E=1-129.
DR   PDB; 2VLR; X-ray; 2.30 A; E/J=1-129.
DR   PDB; 2XN9; X-ray; 2.30 A; B=1-129.
DR   PDB; 2XNA; X-ray; 2.10 A; B=1-129.
DR   PDB; 3ARB; X-ray; 2.70 A; D=1-129.
DR   PDB; 3ARD; X-ray; 3.01 A; D=1-129.
DR   PDB; 3ARE; X-ray; 2.80 A; D=1-129.
DR   PDB; 3ARF; X-ray; 2.90 A; D=1-129.
DR   PDB; 3ARG; X-ray; 3.00 A; D=1-129.
DR   PDB; 3D39; X-ray; 2.81 A; E=1-129.
DR   PDB; 3D3V; X-ray; 2.80 A; E=1-129.
DR   PDB; 3DX9; X-ray; 2.75 A; B/D=1-129.
DR   PDB; 3DXA; X-ray; 3.50 A; E/J/O=1-129.
DR   PDB; 3FFC; X-ray; 2.80 A; E/J=1-129.
DR   PDB; 3HE6; X-ray; 2.90 A; D=1-129.
DR   PDB; 3HG1; X-ray; 3.00 A; E=1-129.
DR   PDB; 3KPR; X-ray; 2.60 A; E/J=1-129.
DR   PDB; 3KPS; X-ray; 2.70 A; E=1-129.
DR   PDB; 3O4L; X-ray; 2.54 A; E=1-129.
DR   PDB; 3TN0; X-ray; 3.20 A; D=1-129.
DR   PDB; 4G8E; X-ray; 2.20 A; B=1-129.
DR   PDB; 4G8F; X-ray; 2.10 A; B=1-129.
DR   PDB; 4GG6; X-ray; 3.20 A; F/H=1-129.
DR   PDB; 4GG8; X-ray; 3.20 A; B/F=1-129.
DR   PDB; 4IIQ; X-ray; 2.86 A; B=1-129.
DR   PDB; 4JFD; X-ray; 2.46 A; E=1-129.
DR   PDB; 4JFE; X-ray; 2.70 A; E=1-129.
DR   PDB; 4JFF; X-ray; 2.43 A; E=1-129.
DR   PDB; 4JFH; X-ray; 2.40 A; E=1-129.
DR   PDB; 4JRX; X-ray; 2.30 A; E=1-129.
DR   PDB; 4JRY; X-ray; 2.80 A; E=1-129.
DR   PDB; 4L4T; X-ray; 2.00 A; E/H=1-129.
DR   PDB; 4L4V; X-ray; 1.90 A; E/H=1-129.
DR   PDB; 4L9L; X-ray; 3.40 A; B=1-129.
DR   PDB; 4LCC; X-ray; 3.26 A; B=1-129.
DR   PDB; 4LCW; X-ray; 2.40 A; E/H=1-129.
DR   PDB; 4MJI; X-ray; 2.99 A; E/J=1-129.
DR   PDB; 4MNQ; X-ray; 2.74 A; E=1-129.
DR   PDB; 4NQC; X-ray; 2.50 A; E/H=1-129.
DR   PDB; 4NQD; X-ray; 2.20 A; E/H=1-129.
DR   PDB; 4NQE; X-ray; 2.10 A; E/H=1-129.
DR   PDB; 4OZF; X-ray; 2.70 A; H=1-129.
DR   PDB; 4OZG; X-ray; 3.00 A; F/H=1-129.
DR   PDB; 4OZH; X-ray; 2.80 A; F/H=1-129.
DR   PDB; 4OZI; X-ray; 3.20 A; F/H=1-129.
DR   PDB; 4P46; X-ray; 2.85 A; B=1-127.
DR   PDB; 4PRH; X-ray; 2.50 A; E=1-129.
DR   PDB; 4PRI; X-ray; 2.40 A; E=1-129.
DR   PDB; 4PRP; X-ray; 2.50 A; E=1-129.
DR   PDB; 4X6B; X-ray; 2.10 A; B/D=1-129.
DR   PDB; 4X6C; X-ray; 2.80 A; F/H=1-129.
DR   PDB; 4X6D; X-ray; 2.98 A; F/H=1-129.
DR   PDB; 4ZDH; X-ray; 2.10 A; B=1-129.
DR   PDB; 7RYL; X-ray; 2.00 A; C=1-129.
DR   PDB; 7RYM; X-ray; 3.20 A; C=1-129.
DR   PDB; 7RYN; X-ray; 2.70 A; C=1-129.
DR   PDB; 7RYO; X-ray; 3.00 A; C=1-129.
DR   PDB; 7T2B; X-ray; 2.80 A; E/J/O/T=1-129.
DR   PDB; 7T2C; X-ray; 3.10 A; E=1-129.
DR   PDB; 7T2D; X-ray; 3.40 A; E/J/O/T=1-129.
DR   PDB; 8RRO; X-ray; 3.50 A; B/G/L/Q/V/a/f/k=1-129.
DR   PDB; 8RVD; X-ray; 3.00 A; A/C/E/F/I/K/M/O=1-129.
DR   PDB; 9BBC; EM; 3.30 A; B=1-172.
DR   PDBsum; 1AO7; -.
DR   PDBsum; 1FYT; -.
DR   PDBsum; 1J8H; -.
DR   PDBsum; 1KGC; -.
DR   PDBsum; 1KTK; -.
DR   PDBsum; 1MI5; -.
DR   PDBsum; 1OGA; -.
DR   PDBsum; 1YMM; -.
DR   PDBsum; 1ZGL; -.
DR   PDBsum; 2AK4; -.
DR   PDBsum; 2AXH; -.
DR   PDBsum; 2BNQ; -.
DR   PDBsum; 2BNR; -.
DR   PDBsum; 2BNU; -.
DR   PDBsum; 2CDE; -.
DR   PDBsum; 2CDF; -.
DR   PDBsum; 2CDG; -.
DR   PDBsum; 2ESV; -.
DR   PDBsum; 2F53; -.
DR   PDBsum; 2F54; -.
DR   PDBsum; 2GJ6; -.
DR   PDBsum; 2IAL; -.
DR   PDBsum; 2IAM; -.
DR   PDBsum; 2IAN; -.
DR   PDBsum; 2NTS; -.
DR   PDBsum; 2NW2; -.
DR   PDBsum; 2NX5; -.
DR   PDBsum; 2P5E; -.
DR   PDBsum; 2P5W; -.
DR   PDBsum; 2PO6; -.
DR   PDBsum; 2PYE; -.
DR   PDBsum; 2PYF; -.
DR   PDBsum; 2VLJ; -.
DR   PDBsum; 2VLK; -.
DR   PDBsum; 2VLM; -.
DR   PDBsum; 2VLR; -.
DR   PDBsum; 2XN9; -.
DR   PDBsum; 2XNA; -.
DR   PDBsum; 3ARB; -.
DR   PDBsum; 3ARD; -.
DR   PDBsum; 3ARE; -.
DR   PDBsum; 3ARF; -.
DR   PDBsum; 3ARG; -.
DR   PDBsum; 3D39; -.
DR   PDBsum; 3D3V; -.
DR   PDBsum; 3DX9; -.
DR   PDBsum; 3DXA; -.
DR   PDBsum; 3FFC; -.
DR   PDBsum; 3HE6; -.
DR   PDBsum; 3HG1; -.
DR   PDBsum; 3KPR; -.
DR   PDBsum; 3KPS; -.
DR   PDBsum; 3O4L; -.
DR   PDBsum; 3TN0; -.
DR   PDBsum; 4G8E; -.
DR   PDBsum; 4G8F; -.
DR   PDBsum; 4GG6; -.
DR   PDBsum; 4GG8; -.
DR   PDBsum; 4IIQ; -.
DR   PDBsum; 4JFD; -.
DR   PDBsum; 4JFE; -.
DR   PDBsum; 4JFF; -.
DR   PDBsum; 4JFH; -.
DR   PDBsum; 4JRX; -.
DR   PDBsum; 4JRY; -.
DR   PDBsum; 4L4T; -.
DR   PDBsum; 4L4V; -.
DR   PDBsum; 4L9L; -.
DR   PDBsum; 4LCC; -.
DR   PDBsum; 4LCW; -.
DR   PDBsum; 4MJI; -.
DR   PDBsum; 4MNQ; -.
DR   PDBsum; 4NQC; -.
DR   PDBsum; 4NQD; -.
DR   PDBsum; 4NQE; -.
DR   PDBsum; 4OZF; -.
DR   PDBsum; 4OZG; -.
DR   PDBsum; 4OZH; -.
DR   PDBsum; 4OZI; -.
DR   PDBsum; 4P46; -.
DR   PDBsum; 4PRH; -.
DR   PDBsum; 4PRI; -.
DR   PDBsum; 4PRP; -.
DR   PDBsum; 4X6B; -.
DR   PDBsum; 4X6C; -.
DR   PDBsum; 4X6D; -.
DR   PDBsum; 4ZDH; -.
DR   PDBsum; 7RYL; -.
DR   PDBsum; 7RYM; -.
DR   PDBsum; 7RYN; -.
DR   PDBsum; 7RYO; -.
DR   PDBsum; 7T2B; -.
DR   PDBsum; 7T2C; -.
DR   PDBsum; 7T2D; -.
DR   PDBsum; 8RRO; -.
DR   PDBsum; 8RVD; -.
DR   PDBsum; 9BBC; -.
DR   AlphaFoldDB; P01850; -.
DR   SMR; P01850; -.
DR   ComplexPortal; CPX-6581; Alpha-beta T cell receptor complex, TRBC1 variant.
DR   FunCoup; P01850; 120.
DR   IntAct; P01850; 3.
DR   DrugBank; DB02740; 3-Indolebutyric Acid.
DR   IMGT_GENE-DB; TRBC1; -.
DR   GlyCosmos; P01850; 1 site, No reported glycans.
DR   GlyGen; P01850; 1 site.
DR   iPTMnet; P01850; -.
DR   PhosphoSitePlus; P01850; -.
DR   BioMuta; ENSG00000211751; -.
DR   BioMuta; HGNC:12156; -.
DR   DMDM; 294862488; -.
DR   MassIVE; P01850; -.
DR   ProteomicsDB; 51492; -.
DR   ABCD; P01850; 10 sequenced antibodies.
DR   AGR; HGNC:12156; -.
DR   GeneCards; TRBC1; -.
DR   HGNC; HGNC:12156; TRBC1.
DR   HPA; ENSG00000211751; Tissue enriched (lymphoid).
DR   MalaCards; TRBC1; -.
DR   MIM; 186930; gene.
DR   InParanoid; P01850; -.
DR   OMA; VLMAMIK; -.
DR   OrthoDB; 9049585at2759; -.
DR   PAN-GO; P01850; 11 GO annotations based on evolutionary models.
DR   PhylomeDB; P01850; -.
DR   PathwayCommons; P01850; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-202427; Phosphorylation of CD3 and TCR zeta chains.
DR   Reactome; R-HSA-202430; Translocation of ZAP-70 to Immunological synapse.
DR   Reactome; R-HSA-202433; Generation of second messenger molecules.
DR   Reactome; R-HSA-389948; Co-inhibition by PD-1.
DR   SignaLink; P01850; -.
DR   SIGNOR; P01850; -.
DR   ChiTaRS; TRBC1; human.
DR   EvolutionaryTrace; P01850; -.
DR   Pharos; P01850; Tdark.
DR   PRO; PR:P01850; -.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; P01850; protein.
DR   GO; GO:0042105; C:alpha-beta T cell receptor complex; ISS:ComplexPortal.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:ComplexPortal.
DR   GO; GO:0002250; P:adaptive immune response; NAS:ComplexPortal.
DR   GO; GO:0046631; P:alpha-beta T cell activation; NAS:ComplexPortal.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; NAS:ComplexPortal.
DR   CDD; cd05769; IgC1_TCR_beta; 1.
DR   FunFam; 2.60.40.10:FF:001090; T cell receptor beta constant 1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR050380; Immune_Resp_Modulators.
DR   PANTHER; PTHR23411; TAPASIN; 1.
DR   Pfam; PF07654; C1-set; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Cell membrane; Disulfide bond;
KW   Glycoprotein; Immunity; Immunoglobulin domain; Membrane;
KW   Proteomics identification; Receptor; Reference proteome; T cell receptor;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           <1..176
FT                   /note="T cell receptor beta constant 1"
FT                   /id="PRO_0000184526"
FT   TRANSMEM        150..170
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        171..176
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          8..117
FT                   /note="Ig-like C1-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   REGION          130..144
FT                   /note="Connecting peptide"
FT                   /evidence="ECO:0000305|PubMed:27791034,
FT                   ECO:0000305|PubMed:9382891"
FT   CARBOHYD        69
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   DISULFID        30..95
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:19167249"
FT   DISULFID        130
FT                   /note="Interchain (with C-94 in TRAC)"
FT                   /evidence="ECO:0000269|PubMed:27791034"
FT   MUTAGEN         139
FT                   /note="Q->F: Impairs signal transduction in response to
FT                   antigenic stimulation."
FT                   /evidence="ECO:0000269|PubMed:9382891"
FT   MUTAGEN         162
FT                   /note="V->F: Reduces TR-CD3 complex assembly."
FT                   /evidence="ECO:0000269|PubMed:27791034"
FT   NON_TER         1
FT   HELIX           2..4
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          9..13
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   HELIX           17..23
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          24..38
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          40..46
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          49..51
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          53..57
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          62..64
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          68..70
FT                   /evidence="ECO:0007829|PDB:2VLM"
FT   STRAND          73..82
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   HELIX           83..86
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:1ZGL"
FT   STRAND          92..99
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:7RYL"
FT   STRAND          110..112
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          116..125
FT                   /evidence="ECO:0007829|PDB:1OGA"
FT   STRAND          129..131
FT                   /evidence="ECO:0007829|PDB:9BBC"
FT   HELIX           134..171
FT                   /evidence="ECO:0007829|PDB:9BBC"
SQ   SEQUENCE   176 AA;  19769 MW;  F029F045A6FC73C5 CRC64;
     DLNKVFPPEV AVFEPSEAEI SHTQKATLVC LATGFFPDHV ELSWWVNGKE VHSGVSTDPQ
     PLKEQPALND SRYCLSSRLR VSATFWQNPR NHFRCQVQFY GLSENDEWTQ DRAKPVTQIV
     SAEAWGRADC GFTSVSYQQG VLSATILYEI LLGKATLYAV LVSALVLMAM VKRKDF
//
